AB225867

Anti-GSDMD antibody [EPR19828] - BSA and Azide free

RabMAb
Recombinant
KO Validated
What is this?

Be the first to review this product! Submit a review

(7 Publications)

Rabbit Recombinant Monoclonal GSDMD antibody. Carrier free. Suitable for IP, WB and reacts with Mouse samples. Cited in 7 publications.

View Alternative Names

Gsdmdc1, Gsdmd, Gasdermin-D, Gasdermin domain-containing protein 1

6 Images

Unknown

Immunoprecipitation - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Gasdermin-D was immunoprecipitated from 0.35 mg of RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus)-derived cells with ectopic expression of ASC (Apoptosis-associated speck-like protein), whole cell lysate with ab209845 at 1/30 dilution.

Western blot was performed from the immunoprecipitate using ab209845 at 1/1000 dilution.

VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : RAW 264.7-derived cells with ectopic expression of ASC whole cell lysate 10ug (Input).

Lane 2 : ab209845 IP in RAW 264.7-derived cells with ectopic expression of ASC whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab209845 in RAW 264.7-derived cells with ectopic expression of ASC whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 3 minutes.

Details of RAW 264.7-derived cells with ectopic expression of ASC are described in the literature : PMID 26611636.

The cells were kindly provided by our collaborator Dr. Jiahuai Han, Xiamen University.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209845).

All lanes:

Immunoprecipitation - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (ab225867)

Predicted band size: 53 kDa

false

Supplier Data

Immunoprecipitation - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Gasdermin-D was immunoprecipitated from 0.35 mg of RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus)-derived cells with ectopic expression of ASC were primed with 1μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h, whole cell lysate with ab209845 at 1/30 dilution.

Western blot was performed from the immunoprecipitate using ab209845 at 1/1000 dilution.

VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : RAW 264.7-derived cells with ectopic expression of ASC were primed with 1μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h, whole cell lysate 10ug (Input).

Lane 2 : ab209845 IP in RAW 264.7-derived cells with ectopic expression of ASC were primed with 1μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h, whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab209845 in RAW 264.7-derived cells with ectopic expression of ASC were primed with 1μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h, whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 3 minutes.

As a response to LPS stimulation and nigericin treatment, Gasdermin-D is cleaved and Gasdermin-D N-terminal form is detected at 32kDa. Details of RAW 264.7-derived cells with ectopic expression of ASC are described in the literature : PMID 26611636.

The cells were kindly provided by our collaborator Dr. Jiahuai Han, Xiamen University.

Note : The antibody has better affinity to full length Gasdermin-D.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209845).

All lanes:

Immunoprecipitation - Anti-GSDMD antibody [EPR19828] (<a href='/en-us/products/primary-antibodies/gsdmd-antibody-epr19828-ab209845'>ab209845</a>) at 1/1000 dilution

Lane 1:

RAW 264.7-derived cells with ectopic expression of ASC were primed with 1μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h at 10 µg

Lane 2:

<a href='/en-us/products/primary-antibodies/gsdmd-antibody-epr19828-ab209845'>ab209845</a> IP in RAW 264.7-derived cells with ectopic expression of ASC were primed with 1μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h whole cell lysate at 10 µg

Lane 3:

Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of <a href='/en-us/products/primary-antibodies/gsdmd-antibody-epr19828-ab209845'>ab209845</a> in RAW 264.7-derived cells with ectopic expression of ASC were primed with 1μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h whole cell lysate

Predicted band size: 53 kDa

false

Lab

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Blocking and dilution buffer : 5% NFDM/TBST.

This data was developed using the same antibody clone in a different buffer formulation (ab209845).

All lanes:

Western blot - Anti-GSDMD antibody [EPR19828] (<a href='/en-us/products/primary-antibodies/gsdmd-antibody-epr19828-ab209845'>ab209845</a>) at 1/1000 dilution

Lane 1:

J774A.1 (Mouse reticulum cell sarcoma monocyte macrophage) whole cell lysate at 20 µg

Lane 2:

J774A.1 (Mouse reticulum cell sarcoma monocyte macrophage) treated with 100ng/ml lipopolysaccharides (LPS) for 3h, then added 300ng/ml BFA for another 3h whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 53 kDa

Observed band size: 53 kDa

false

Exposure time: 180s

Lab

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

This data was developed using ab209845, the same antibody clone in a different buffer formulation. Different batches of ab209845 were tested on :

1 : RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) -derived cell line with ectopic expression of ASC primed with 1 μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 uM nigericin treatment under serum starved conditions for 2 h, whole cell lysate at 5.2 μg/ml.

2 : RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) -derived cell line with ectopic expression of ASC (Apoptosis-associated speck-like protein), whole cell lysate at 5.2 μg/ml.

15 μg of lysate was loaded in each lane. Bands observed at 32,53 kDa.

All lanes:

Western blot - Anti-GSDMD antibody [EPR19828] (<a href='/en-us/products/primary-antibodies/gsdmd-antibody-epr19828-ab209845'>ab209845</a>)

Predicted band size: 53 kDa

false

Supplier Data

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Blocking/Dilution buffer : 5% NFDM/TBST.

As a response to LPS stimulation and nigericin treatment, Gasdermin-D is cleaved and Gasdermin-D N-terminal form is detected at 32kDa. Details of RAW264.7-derived cells with ectopic expression of ASC are described in the literature : PMID 26611636

The MW observed is consistent with the literature : PMID 26375003.

The cells were kindly provided by our collaborator Dr. Jiahuai Han, Xiamen University.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209845).

All lanes:

Western blot - Anti-GSDMD antibody [EPR19828] (<a href='/en-us/products/primary-antibodies/gsdmd-antibody-epr19828-ab209845'>ab209845</a>) at 1/1000 dilution

Lane 1:

RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus)-derived cell line with ectopic expression of ASC (Apoptosis-associated speck-like protein), whole cell lysate at 20 µg

Lane 2:

RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus)-derived cell line with ectopic expression of ASC primed with 1 μg/mL lipopolysaccharides (LPS) for 4 h followed by 10 μM nigericin treatment under serum starved conditions for 2 h, whole cell lysate at 20 µg

Lane 3:

Gasdermin-D knockout RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus)-derived cell line with ectopic expression of ASC whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 53 kDa

Observed band size: 32 kDa,53 kDa

false

Exposure time: 1min

Lab

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

This data was developed using ab209845, the same antibody clone in a different buffer formulation.

Compared with ab209845, ab219800 has a higher affinity in positive samples.

The MW observed is consistent with the literature : PMID 26375003.

The 43 kDa band is likely to be a GSDMD cleavage product by caspase-3 at GSDMD Asp88 (PMID : 30902848, PMID : 28392147, PMID : 30135078).

We are unsure how to define the 37kDa extra band.

Other bands may be the GSDMD cleavage products, you can find them in PMID : 34890644, PMID : 33208231, PMID : 28679757.

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-GSDMD antibody [EPR19828] (<a href='/en-us/products/primary-antibodies/gsdmd-antibody-epr19828-ab209845'>ab209845</a>) at 1/1000 dilution

Lane 1:

RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate, Batch 1 at 20 µg

Lane 2:

Mouse liver lysate at 20 µg

Lane 3:

NIH/3T3 (mouse embyro fibroblast cell line) whole cell lysate at 20 µg

Lane 4:

RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate, Batch 2 at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 53 kDa

Observed band size: 53 kDa

false

Exposure time: 120s

Unconjugated

Anti-GSDMD antibody [EPR19828]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19828

Isotype

IgG

Carrier free

Yes

Reacts with

Mouse

Applications

WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

In our hands this product works well in western blot using mouse cell lines but not tissue samples.

We recommend ab219800 as an alternative for low expression samples.

Expression level of GSDMD in whole normal brain lysate is low or undetectable (PMID: 32671214, PMID: 34975487).

Please navigate to the Product Protocol section for specificity details in Chinese.

style

left-column

style

left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

style

left-column

Product details

ab225867 is the carrier-free version of ab209845.

Patented technology
Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar^® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar^® is a trademark of Fluidigm Canada Inc.

style

left-column

Properties and storage information

Form

Liquid

Purification technique

Affinity purification Protein A

Storage buffer

pH: 7.2 - 7.4 Constituents: PBS

Shipped at conditions

Blue Ice

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

+4°C

Storage information

Do Not Freeze

style

left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GSDMD also known as gasdermin D is a protein known for its role in pyroptosis a form of programmed cell death. Its molecular weight is approximately 53 kDa. Mechanically GSDMD operates by forming pores in cell membranes. These pores disrupt cellular homeostasis and eventually lead to cell lysis. GSDMD is mainly expressed in immune cells including macrophages and neutrophils. Researchers frequently use GSDMD Western blot and GSDMD ELISA for its detection and quantification in various studies.

Biological function summary

Gasdermin D functions in the execution of immune responses against infections. It acts as an effector molecule that participates directly in pyroptosis by disrupting mitochondrial membranes. GSDMD operates as part of a larger inflammasome complex initiated by inflammatory signals. The inflammasome activates inflammatory caspases that cleave GSDMD enabling its active form to execute pyroptosis. This process releases cytokines like IL-1? enhancing the inflammatory response.

Pathways

GSDMD is important in the pyroptosis pathway initiated by the inflammasome. This process involves Caspase-1 a protease responsible for cleaving pro-inflammatory cytokines and initiating pyroptosis. Another significant pathway includes NLRP3 inflammasome which acts upstream to activate Caspase-1 and subsequently GSDMD establishing the overall inflammatory response in the innate immune system. Through these pathways GSDMD interacts closely with proteins like IL-18 an essential inflammatory mediator.

Gasdermin D has links to inflammatory diseases such as rheumatoid arthritis and sepsis. In rheumatoid arthritis the excessive activation of GSDMD leads to chronic joint inflammation mediated by activated immune cells. In sepsis over-activation of the pyroptosis pathway may cause severe systemic inflammation driven by GSDMD activity exacerbating cytokine release. Connections exist between GSDMD and other proteins such as Caspase-11 which can also initiate GSDMD cleavage independently and has roles in non-canonical inflammasome pathways influencing these conditions.

style

left-column

style

left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

style

left-column

Target data

Gasdermin-D. Precursor of a pore-forming protein that plays a key role in host defense against pathogen infection and danger signals (PubMed : 26375003, PubMed : 26375259, PubMed : 26611636, PubMed : 27383986, PubMed : 27385778, PubMed : 27418190). This form constitutes the precursor of the pore-forming protein : upon cleavage, the released N-terminal moiety (Gasdermin-D, N-terminal) binds to membranes and forms pores, triggering pyroptosis (PubMed : 26375003, PubMed : 26375259, PubMed : 26611636, PubMed : 27383986, PubMed : 27385778, PubMed : 27418190).. Gasdermin-D, N-terminal. Promotes pyroptosis in response to microbial infection and danger signals (PubMed : 26375003, PubMed : 26375259, PubMed : 26611636, PubMed : 27383986, PubMed : 27385778, PubMed : 27418190, PubMed : 32820063, PubMed : 34289345, PubMed : 35705808, PubMed : 37988464, PubMed : 38530158, PubMed : 38538834, PubMed : 38632402). Produced by the cleavage of gasdermin-D by inflammatory caspases CASP1 or CASP4/CASP11 in response to canonical, as well as non-canonical (such as cytosolic LPS) inflammasome activators (PubMed : 26375003, PubMed : 26375259, PubMed : 26611636, PubMed : 27383986, PubMed : 27385778, PubMed : 27418190, PubMed : 35705808, PubMed : 38632402). After cleavage, moves to the plasma membrane where it strongly binds to inner leaflet lipids, including monophosphorylated phosphatidylinositols, such as phosphatidylinositol 4-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate, as well as phosphatidylinositol (3,4,5)-bisphosphate, and more weakly to phosphatidic acid and phosphatidylserine (PubMed : 27339137, PubMed : 27383986). Homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, allowing the release of mature interleukin-1 (IL1B and IL18) and triggering pyroptosis (PubMed : 27383986, PubMed : 29195811, PubMed : 29274245, PubMed : 33883744, PubMed : 38530158, PubMed : 38538834). Gasdermin pores also allow the release of mature caspase-7 (CASP7) (PubMed : 35705808). In some, but not all, cells types, pyroptosis is followed by pyroptotic cell death, which is caused by downstream activation of ninjurin-1 (NINJ1), which mediates membrane rupture (cytolysis) (PubMed : 38632402). Also forms pores in the mitochondrial membrane, resulting in release of mitochondrial DNA (mtDNA) into the cytosol (PubMed : 37001519). Gasdermin-D, N-terminal released from pyroptotic cells into the extracellular milieu rapidly binds to and kills both Gram-negative and Gram-positive bacteria, without harming neighboring mammalian cells, as it does not disrupt the plasma membrane from the outside due to lipid-binding specificity (PubMed : 27383986). Under cell culture conditions, also active against intracellular bacteria, such as Listeria monocytogenes (PubMed : 27383986). Also active in response to MAP3K7/TAK1 inactivation by Yersinia toxin YopJ, which triggers cleavage by CASP8 and subsequent activation (PubMed : 30361383, PubMed : 30381458). Required for mucosal tissue defense against enteric pathogens (PubMed : 37988464). Activation of the non-canonical inflammasome in brain endothelial cells can lead to excessive pyroptosis, leading to blood-brain barrier breakdown (PubMed : 38632402). Strongly binds to bacterial and mitochondrial lipids, including cardiolipin. Does not bind to unphosphorylated phosphatidylinositol, phosphatidylethanolamine nor phosphatidylcholine (PubMed : 27383986).. Gasdermin-D, p13. Transcription coactivator produced by the cleavage by CASP3 or CASP7 in the upper small intestine in response to dietary antigens (PubMed : 37327784). Required to maintain food tolerance in small intestine : translocates to the nucleus and acts as a coactivator for STAT1 to induce the transcription of CIITA and MHC class II molecules, which in turn induce type 1 regulatory T (Tr1) cells in upper small intestine (PubMed : 37327784).. Gasdermin-D, p40. Produced by the cleavage by papain allergen (PubMed : 35794369). After cleavage, moves to the plasma membrane and homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, allowing the specific release of mature interleukin-33 (IL33), promoting type 2 inflammatory immune response (PubMed : 35749514, PubMed : 35794369).

See full target information Gsdmd

style

left-column

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:426 PubMed40456737

2025

FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death.

Applications

Unspecified application

Species

Unspecified reactive species

Byeong-Ju Kim,Sun Mi Hong,Hyun-Jin Noh,Jihye Kim,Su-Yeon Seon,Jeong-Eun Lee,Da-Hye Jeong,Ju-Mi Park,Sejeong Park,Sanghoon Lee,Jaewoo Kang,Dakeun Lee,Michael J Morgan,You-Sun Kim

International journal of oncology 66: PubMed39950328

2025

Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote NLRP3‑dependent pyroptosis in non‑small cell lung cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yunzhu Xi,Saili Zeng,Xiaowu Tan,Xiaoyu Deng

Functional & integrative genomics 24:55 PubMed38467948

2024

Huang Qin decoction increases SLC6A4 expression and blocks the NFκB-mediated NLRP3/Caspase1/GSDMD pathway to disrupt colitis-associated carcinogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Yili Tao,Lai Wang,Xiaofeng Ye,Xin Qian,Danye Pan,Xiaoyu Dong,Qian Jiang,Po Hu

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2303177 PubMed38308188

2024

NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Sun Mi Hong,A-Yeon Lee,Byeong-Ju Kim,Jeong-Eun Lee,Su-Yeon Seon,Yu-Jin Ha,Jestlin Tianthing Ng,Gyesoon Yoon,Su Bin Lim,Michael J Morgan,Jong-Ho Cha,Dakeun Lee,You-Sun Kim

Gut microbes 15:2180315 PubMed36803521

2023

effector SopF regulates PANoptosis of intestinal epithelial cells to aggravate systemic infection.

Applications

Unspecified application

Species

Unspecified reactive species

Haibo Yuan,Liting Zhou,Yilin Chen,Jiayi You,Hongye Hu,Yuanyuan Li,Rui Huang,Shuyan Wu

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 41:376-383 PubMed33849828

2021

[Changes of guanylate cyclase C in colon tissues of rats with intestinal injury associated with severe acute pancreatitis].

Applications

Unspecified application

Species

Unspecified reactive species

B Wang,Q Huang,S Li,J Wu,X Yuan,H Sun,L Tang

Toxicology and applied pharmacology 377:114626 PubMed31201821

2019

Microcystin-LR promotes necroptosis in primary mouse hepatocytes by overproducing reactive oxygen species.

Applications

Unspecified application

Species

Unspecified reactive species

Yun-Li Wu,Yun He,Jia-Jian Shi,Tian-Xiu Zheng,Xin-Jian Lin,Xu Lin

View all publications

style

left-column

style

left-column

websiteProtocolBooklet

style

right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.

For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

Anti-GSDMD antibody [EPR19828] - BSA and Azide free

Immunoprecipitation - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Immunoprecipitation - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Western blot - Anti-GSDMD antibody [EPR19828] - BSA and Azide free (AB225867)

Related conjugates and formulations (1)

Key facts

Host species

Clonality

Clone number

Isotype

Carrier free

Reacts with

Applications

Immunogen

Specificity

Alternative Products

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Complementary Products

Assay Kits

Primary Antibodies

Primary Antibodies

Primary Antibodies

Secondary Antibodies

Reactivity data

Product details

Properties and storage information

Form

Purification technique

Storage buffer

Shipped at conditions

Appropriate short-term storage conditions

Appropriate long-term storage conditions

Storage information

Supplementary information

Biological function summary

Pathways

Product protocols

Target data

Publications (7)

Product promise